High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda

被引:58
|
作者
Elul, Batya [1 ,2 ]
Basinga, Paulin [3 ,4 ]
Nuwagaba-Biribonwoha, Harriet [1 ]
Saito, Suzue [1 ,2 ]
Horowitz, Deborah [1 ]
Nash, Denis [2 ,5 ]
Mugabo, Jules [6 ]
Mugisha, Veronicah [1 ]
Rugigana, Etienne [3 ]
Nkunda, Richard [7 ]
Asiimwe, Anita [6 ]
机构
[1] Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY 10027 USA
[2] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA
[3] Natl Univ Rwanda, Sch Publ Hlth, Dept Community Hlth, Kigali, Rwanda
[4] Bill & Melinda Gates Fdn, Seattle, WA USA
[5] CUNY Hunter Coll, Epidemiol & Biostat Program, Sch Publ Hlth, New York, NY 10021 USA
[6] Minist Hlth, RBC, Kigali, Rwanda
[7] NRL, Kigali, Rwanda
来源
PLOS ONE | 2013年 / 8卷 / 01期
关键词
SELF-REPORTED ADHERENCE; SUB-SAHARAN AFRICA; IMMUNOLOGICAL OUTCOMES; PREDICTORS; PROGRAM; HAART; TRIAL;
D O I
10.1371/journal.pone.0053586
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Generalizable data are needed on the magnitude and determinants of adherence and virological suppression among patients on antiretroviral therapy (ART) in Africa. Methods: We conducted a cross-sectional survey with chart abstraction, patient interviews and site assessments in a nationally representative sample of adults on ART for 6, 12 and 18 months at 20 sites in Rwanda. Adherence was assessed using 3- and 30-day patient recall. A systematically selected sub-sample had viral load (VL) measurements. Multivariable logistic regression examined predictors of non-perfect (<100%) 30-day adherence and detectable VL (>40 copies/ml). Results: Overall, 1,417 adults were interviewed and 837 had VL measures. Ninety-four percent and 78% reported perfect adherence for the last 3 and 30 days, respectively. Eighty-three percent had undetectable VL. In adjusted models, characteristics independently associated with higher odds of non-perfect 30-day adherence were: being on ART for 18 months (vs. 6 months); younger age; reporting severe (vs. no or few) side effects in the prior 30 days; having no documentation of CD4 cell count at ART initiation (vs. having a CD4 cell count of <200 cells/mu L); alcohol use; and attending sites which initiated ART services in 2003-2004 and 2005 (vs. 2006-2007); sites with >= 600 (vs. <600 patients) on ART; or sites with peer educators. Participation in an association for people living with HIV/AIDS; and receiving care at sites which regularly conduct home-visits were independently associated with lower odds of non-adherence. Higher odds of having a detectable VL were observed among patients at sites with peer educators. Being female; participating in an association for PLWHA; and using a reminder tool were independently associated with lower odds of having detectable VL. Conclusions: High levels of adherence and viral suppression were observed in the Rwandan national ART program, and associated with potentially modifiable factors.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Viral Suppression in a Nationwide Sample of HIV-Infected Children on Antiretroviral Therapy in Rwanda
    Nsanzimana, Sabin
    McArdle, Flannery
    Remera, Eric
    Mulindabigwi, Augustin
    Ribakare, Muhayimpundu
    Ndimubanzi, Patrick
    Kayirangwa, Eugenie
    Baribwira, Cyprien
    Riedel, David J.
    Ntaganira, Joseph
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (02) : 149 - 151
  • [2] Timing of Antiretroviral Therapy Initiation in a Nationally Representative Sample of HIV-Infected Adults Receiving Medical Care in the United States
    Adedinsewo, Demilade A.
    Wei, Stanley C.
    Robertson, McKaylee
    Rose, Charles
    Johnson, Christopher H.
    Dombrowski, Julie
    Skarbinski, Jacek
    [J]. AIDS PATIENT CARE AND STDS, 2014, 28 (12) : 613 - 621
  • [3] Antiretroviral therapy adherence and viral suppression among HIV-infected adolescents and young adults at a tertiary hospital in Ghana
    Biney, Isaac Justice Kobina
    Kyei, Kofi Adesi
    Ganu, Vincent Jessey
    Kenu, Ernest
    Puplampu, Peter
    Manortey, Steven
    Lartey, Margaret
    [J]. AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2021, 20 (04): : 270 - 276
  • [4] Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression
    Siefried, Krista J.
    Mao, Limin
    Kerr, Stephen
    Cysique, Lucette A.
    Gates, Thomas M.
    McAllister, John
    Maynard, Anthony
    de Wit, John
    Carr, Andrew
    [J]. PLOS ONE, 2017, 12 (04):
  • [5] Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy
    Bon, Isabella
    Musumeci, Giuseppina
    Pavoni, Michele
    Miserocchi, Anna
    Lo Presti, Alessandra
    Morini, Silvia
    Caio, Giacomo
    Della Vittoria, Agnese
    Gibellini, Davide
    Re, Maria Carla
    [J]. NEW MICROBIOLOGICA, 2015, 38 (02): : 289 - 292
  • [6] Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy
    Yehia, Baligh R.
    Fleishman, John A.
    Metlay, Joshua P.
    Moore, Richard D.
    Gebo, Kelly A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (04): : 339 - 342
  • [7] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Arnsten, JH
    Demas, PA
    Grant, RW
    Gourevitch, MN
    Farzodegan, H
    Howard, AA
    Schoenboum, EE
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) : 377 - 381
  • [8] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Julia H. Arnsten
    Penelope A. Demas
    Richard W. Grant
    Marc N. Gourevitch
    Homayoon Farzadegan
    Andrea A. Howard
    Ellie E. Schoenbaum
    [J]. Journal of General Internal Medicine, 2002, 17 : 377 - 381
  • [9] Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa
    Nachega, JB
    Stein, DM
    Lehman, DA
    Hlatshwayo, D
    Mothopeng, R
    Chaisson, RE
    Karstaedt, AS
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (10) : 1053 - 1056
  • [10] Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
    Glass, Tracy R.
    Rotger, Margalida
    Telenti, Amalio
    Decosterd, Laurent
    Csajka, Chantal
    Bucher, Heiner C.
    Guenthard, Huldrych F.
    Rickenbach, Martin
    Nicca, Dunja
    Hirschel, Bernard
    Bernasconi, Enos
    Wandeler, Gilles
    Battegay, Manuel
    Marzolini, Catia
    [J]. PLOS ONE, 2012, 7 (01):